| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8841463 | Neuroscience Letters | 2018 | 19 Pages |
Abstract
This study supports the utility of polyQ genetic testing in the differential diagnosis of MSA, and may suggest a possible role of SCA1 repeat length as risk factor for MSA-C. SCA1 and SCA2 genetic screening is recommended in MSA Italian patients.
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
Alessia Mongelli, Lidia Sarro, Elena Rizzo, Lorenzo Nanetti, Nicoletta Meucci, Gianni Pezzoli, Stefano Goldwurm, Franco Taroni, Caterina Mariotti, Cinzia Gellera,